Anna Coles, MD
Pain Medicine · Kalispell, MTNPI 1639565005
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,406 of the $3,140 with a category attached, or 76.6%. Abbott accounts for 73.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $2,280 and has fallen 99.1% since, to $21 in 2025.
Across 22 payments — averaging $142.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$643
- Boston Scientific$130
- Hydrocision, Inc.$45
- AbbVie$21
What the payments were for
- Travel & lodging$2,40677%
- Food & beverage$73423%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $2,301 |
| Medtronic | 7 | $643 |
| Boston Scientific | 1 | $130 |
| Hydrocision, Inc. | 1 | $45 |
| AbbVie | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,130
- RESTORE$403
- VECTRIS$140
- SPECTRA WAVEWRITER$130
How this compares
Too few pain medicine providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 91 | $27,440 |
| LyricaPregabalin | 11 | $8,359 |
| Fentanyl | 44 | $7,609 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 14 | $6,356 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 246 | $5,814 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 367 | $5,610 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 27 | $4,583 |
| Pregabalin | 196 | $2,737 |
| Duloxetine Hcl | 104 | $2,018 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $1,940 |
| Lidocaine | 13 | $1,731 |
| Gabapentin | 144 | $1,633 |
| Celecoxib | 102 | $1,245 |
| Memantine Hcl | 16 | $778 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 13 | $701 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Kalispell
- Timothy StrigenzBozeman$10K
- Patrick DanaherMissoula$6K
- Katrina LewisGreat Falls$6K
- Aaron CrossHelena$5K
- S Dante OrienteGreat Falls$2K
- Craig SweeneyGreat Falls$1K
- Steven MartiniAnaconda$934
- Oscar HeymanMissoula$464
- Brett BenderMissoula$273
- Bradley AylorBozeman$184
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.